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ABSTRACT
ObjeCtives
To estimate the potential impact of universal screening 
for primary prevention of cardiovascular disease 
(National Health Service Health Checks) on disease 
burden and socioeconomic inequalities in health in 
England, and to compare universal screening with 
alternative feasible strategies.
Design
Microsimulation study of a close-to-reality synthetic 
population. Five scenarios were considered: baseline 
scenario, assuming that current trends in risk factors 
will continue in the future; universal screening; 
screening concentrated only in the most deprived 
areas; structural population-wide intervention; and 
combination of population-wide intervention and 
concentrated screening.
setting
Synthetic population with similar characteristics to the 
community dwelling population of England.
PartiCiPants
 Synthetic people with traits informed by the health 
survey for England.
Main OutCOMe Measure
Cardiovascular disease cases and deaths prevented or 
postponed by 2030, stratified by fifths of socioeconomic 
status using the index of multiple deprivation.
results
Compared with the baseline scenario, universal 
screening may prevent or postpone approximately 
19 000 cases (interquartile range 11 000-28 000) and 
3000 deaths (−1000-6000); concentrated screening 
17 000 cases (9000-26 000) and 2000 deaths 
(−1000-5000); population-wide intervention 67 000 
cases (57 000-77 000) and 8000 deaths (4000-11 000); 
and the combination of the population-wide 
intervention and concentrated screening 82 000 cases 
(73 000-93 000) and 9000 deaths (6000-13 000). The 
most equitable strategy would be the combination of 
the population-wide intervention and concentrated 
screening, followed by concentrated screening alone 
and the population-wide intervention. Universal 
screening had the least apparent impact on 
socioeconomic inequalities in health.
COnClusiOns
When primary prevention strategies for reducing 
cardiovascular disease burden and inequalities are 
compared, universal screening seems less effective 
than alternative strategies, which incorporate 
population-wide approaches. Further research is 
needed to identify the best mix of population-wide and 
risk targeted CVD strategies to maximise cost 
effectiveness and minimise inequalities.
Introduction
Cardiovascular disease (CVD) is the leading cause of 
death worldwide.1  Furthermore, substantial socioeco-
nomic inequalities have been observed in CVD mortal-
ity in England and elsewhere.2 3 These inequalities 
powerfully reflect much greater premature mortality, 
and hence shorter life expectancy, among the most 
deprived groups. In England, the current governmental 
action plan to tackle the burden of CVD includes a pro-
gramme known as NHS (National Health Service) 
Health Checks. Introduced in 2009, this programme 
promotes the screening of all healthy adults aged 40 to 
74 for CVD risk stratification, and treatment of those at 
high risk.4 5 Recently, the debate about the programme’s 
scientific foundation, effectiveness, and cost effective-
ness, however, has been heated.6-10 Despite the contro-
versy, the programme remains policy.
Beyond the obvious importance of the debate to 
national public health, the programme’s relevance 
extends internationally. Choices about public health 
policy in the United Kingdom influence policy world-
wide; the UK policies on tobacco control and salt reduc-
tion are two recent examples.11 12 In essence, the debate 
about NHS Health Checks originates from the arche-
typal debate of targeted “high risk” versus “popula-
tion-wide” preventive interventions that was first 
articulated by Geoffrey Rose.13 Rose argued that 
WhAT IS AlReAdy knoWn on ThIS TopIC
Two main strategies for the primary prevention of cardiovascular disease (CVD) is to 
screen the population, find those individuals at high risk, and treat them or to 
reduce the CVD risk of the whole population irrespective of individuals’ baseline risk
Evidence suggests that the second approach is more effective and likely more 
equitable, yet this depends on the distribution of CVD risk throughout the population
In England, the Department of Health adopted the first approach, although this 
decision has recently attracted some criticism
WhAT ThIS STudy AddS
In England, despite the observed higher concentration of CVD risk in more deprived 
areas, structural population-wide interventions targeting unhealthy diet and 
tobacco might be three times more effective than the existing screening policy
Structural population-wide interventions are also likely to be more equitable than 
screening
A comprehensive strategy, combining structural population-wide interventions with 
screening in the most deprived areas (where CVD risk is concentrated) is most likely 
to maximise both effectiveness and equity of primary CVD prevention
doi: 10.1136/bmj.i2793 | BMJ 2016;353:i2793 | the bmj
RESEARCH
2
 population-wide interventions are more effective than 
ones aimed at high risk groups because the majority of 
incident cases occur in the multitudinous group of peo-
ple at low and intermediate risk. In Rose terminology, 
NHS Health Checks is a typical “high risk intervention,” 
as it targets people at high risk rather than lowering risk 
in the whole population.
The effectiveness of high risk interventions for CVD 
prevention has been previously challenged.14  More 
recently, a Cochrane systematic review and the Inter99 
trial found no benefits of health checks on CVD morbid-
ity or mortality.15 16  There were, however, major limita-
tions to these studies: Inter99 trialled a counselling 
intervention not supported by additional drug treat-
ment, and in the Cochrane review nine out of 14 trials 
were conducted before 1980, when the treatment 
options for high risk people were limited. In addition, 
high risk interventions may be more effective in 
 populations with high clustering of risk factors, result-
ing in a high concentration of the risk to certain groups 
in the population.17  In fact, the English population has 
such characteristics, with the risk of CVD being higher 
among those in the most socioeconomically deprived 
groups.18
High risk interventions may generate health inequal-
ities because they require active participation of people 
in both screening and treatment of those at high risk, 
favouring those with more resources.14 19-21  The particu-
lar effect of NHS Health Checks on socioeconomic 
health inequalities remains unclear however. A 
national study reported no difference in the coverage of 
the intervention by deprivation,22  whereas several 
smaller, but more detailed, studies showed substan-
tially lower uptake in deprived areas.23-25
We estimated the potential impact of universal 
screening for primary prevention of CVD on disease 
burden and socioeconomic health inequalities in 
England. Available data on the effectiveness of the NHS 
Health Check programme have been used to model this 
scenario. We further compared universal CVD screening 
with an alternative approach targeting only deprived 
areas, a feasible population-wide intervention, and a 
combination of both.
Methods
Building on experience from the original, validated 
IMPACT model26 and the more recent IMPACTSEC27  and 
IMPACT2 models,28 we created IMPACTNCD, a discrete 
time dynamic stochastic microsimulation model. 
IMPACTNCD simulates the life course of synthetic indi-
viduals under different counterfactual scenarios, up to 
2030 (the projection horizon). During the simulation, 
CVD incidence and CVD and non-CVD mortality are 
recorded. The results are stratified by year, five year age 
group, sex, and fifths of index of multiple deprivation. 
The last is a relative measure of area deprivation that is 
widely used by public health authorities in England, 
and it has been used as the measure of socioeconomic 
classification for this study.29
A more detailed description of the model is provided 
in the supplementary material and the source code is 
available at https://github.com/ChristK/IMPACTncd/
tree/CVD-policy-options.
scenarios
We considered five scenarios.
Baseline (current trends)
In the baseline scenario, we assumed that the recent 
observed trends in CVD risk factor trajectories by age, 
sex, and socioeconomic status will continue in the near 
future. We extracted the trends from the health survey 
for England 2001-12, a nationally representative series 
of health surveys conducted in England annually.30-42
Universal screening
This scenario modelled the potential health effects of 
universal screening to identify and treat people at high 
risk for CVD. Input variables were informed from cur-
rent implementation of the NHS Health Check pro-
gramme. Eligible people were defined as adults aged 
between 40 and 74, excluding those with a known his-
tory of CVD, atrial fibrillation, diabetes mellitus, rheu-
matoid arthritis, or renal disease; closely resembling 
real life eligibility criteria. Based on existing evidence 
we assumed an uptake of 50% for screening,43  and we 
calibrated the distribution of the estimated 10 year 
risk of developing CVD among those participating: 
70% with a less than 10% risk, 25% with between 10% 
and 20%, and 5% with more than 20%.22  In addition, 
we calibrated the age distribution so that around 30% 
of those screened were older than 60.22  Participants 
with a higher than 10% estimated 10 year risk of devel-
oping CVD were considered at high risk and eligible 
for treatment. We used the QRISK2 score to estimate 
the 10 year risk of developing CVD, as perceived from 
healthcare.44
Based on published evidence, we assumed that about 
24% with an estimated risk of 20% or more and total 
cholesterol of 5 mmol/L or more will be prescribed ator-
vastatin 20 mg and about 27% with an estimated risk of 
20% or more and a systolic blood pressure of 135 mm Hg 
or more will be prescribed antihypertensive drugs. For 
those with a risk between 10% and 20% we assumed 
that about 17% and 20% will be prescribed treatment, 
respectively.45  We assumed an 80% persistence with 
treatment and a mean adherence of approximately 70%, 
roughly based on evidence from Denmark.46 Moreover, 
we modelled high risk participants with a body mass 
index of more than 50 kg/m2 to undergo bariatric surgery 
and reduce their body mass index to 30 kg/m2. We 
assumed that with lifestyle counselling half of the high 
risk participants consuming fewer than five fruit and 
vegetable portions daily will increase their consumption 
by a portion daily. Half of those being active for less than 
five days a week will increase their physical activity by 
an active day each week, and all high risk participants 
will decrease their body mass index by around 1%.45 47 
Finally, we modelled 10% of high risk smokers to achieve 
cessation for a year and have a probability of relapse 
equal to that of the general population by sex, fifth of 
multiple deprivation, and years since cessation.48 49
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Concentrated screening
In the concentrated screening scenario, we simulated a 
hypothetical strategy where screening had only been 
implemented in the most deprived fifths (groups 4 and 
5), the groups with the greatest concentration of CVD 
risk. We assumed that the uptake of the intervention 
was 50% and the risk and age distribution in the partic-
ipants was similar to that in the eligible population. 
Otherwise, the strategy is similar to the previous univer-
sal screening scenario. Given the recent criticism about 
the cost and cost effectiveness of the intervention,9 
offering the intervention where the risk is more concen-
trated may reduce costs.
Population-wide intervention
This scenario modelled the effects of a feasible popula-
tion-wide structural intervention targeting unhealthy 
diet and smoking. Several studies have found that a tax 
on sugar sweetened beverages may reduce the preva-
lence of obesity.50-52 For this scenario we assumed that 
such a tax may reduce the mean increase in body mass 
index by about 5% annually. Moreover, the United 
Kingdom has had one of the world’s most successful 
salt reduction strategies, including public awareness 
campaigns, food labelling, and voluntary reformula-
tion of processed foods.53  Modelling studies suggested 
that the addition of mandatory reformulation of pro-
cessed foods may further reduce mean systolic blood 
pressure by 0.8 mm Hg;54 we modelled this decrease. 
A large randomised trial in the United States showed 
that subsidies on fruits and vegetables may increase 
consumption by about half a portion daily, and a mod-
elling study in the UK found that subsidising fruits and 
vegetables combined with taxation of unhealthy foods 
may increase fruit and vegetable annual consumption 
by about 10%.55 56  We modelled an increase of a por-
tion of fruit and vegetable each day in 50% of the 
 population. Finally, a SimSmoke modelling study 
 estimated that full compliance with the framework 
 convention on tobacco control may reduce smoking 
prevalence by 13% (relative) in five years;57 we mod-
elled this decrease.
Population-wide intervention and concentrated 
screening
This scenario is the combination of the population-wide 
intervention and concentrated screening strategies. 
We modelled the implementation of a population-wide 
strategy identical to the previous scenario, comple-
mented by concentrated screening for people at high 
risk of CVD in the most deprived fifths (groups 4 and 5).
Common scenario assumptions
All interventions begun in 2011 and were linearly dif-
fused into the population over a five year period. Trends 
in population risk factors were assumed to be the same 
as those of the baseline scenario for all but the popula-
tion-wide intervention. All of the scenarios assumed 
that CVD case fatality will keep improving by 3% (rela-
tive) annually. In addition, we assumed a socioeco-
nomic gradient in CVD case fatality, forcing the more 
deprived people to experience worse outcomes. Both 
case fatality assumptions were based on recent trends 
and are supported by the British Heart Foundation’s 
statistics on coronary heart disease.2 Finally, a five year 
lag time was assumed between exposure to cardiovas-
cular risk factors and disease.
Model description
Inputs and logic
IMPACTNCD synthesises information from the Office for 
National Statistics and the health surveys for England 
on the English population’s demographics and its expo-
sure to CVD associated risk factors, to generate a 
close-to-reality synthetic population.58 Well established 
causal pathways between CVD and the associated 
risk factors are used to translate exposure into 
CVD   incidence and mortality, in a competing risk 
framework. We obtained effect sizes for exposures 
from published meta-analyses and longitudinal studies 
(see supplementary table S1).
The risk factors we considered for this study were 
age, sex, fifth of deprivation, body mass index, systolic 
blood pressure, total cholesterol level, diabetes melli-
tus (diagnosis or increased glycated haemoglobin 
level/no diabetes), smoking status (current, former, or 
never smoker), environmental tobacco exposure 
(binary variable), fruit and vegetable consumption 
(portions daily), and physical activity (days with at 
least 30 minutes of moderate or vigorous physical 
activity each week). CVD was defined as the sum of 
coronary heart disease and stroke (any type) cases. As 
this study focuses on primary prevention, we consid-
ered only the first ever episode of coronary heart dis-
ease or stroke. The competing risk framework allowed 
people to develop coronary heart disease and/or 
stroke separately, and to die from these two diseases 
or any other cause.
Model outputs
We report the cumulative estimates of cases and deaths 
prevented or postponed as measures of overall effec-
tiveness of the modelled interventions. To measure the 
impact of the modelled interventions on absolute and 
relative socioeconomic health inequalities, we devel-
oped and used two regression based metrics inspired 
by the slope index of inequality;59 the absolute equity 
slope index and the relative equity slope index. The 
absolute equity slope index measures the impact of an 
intervention on absolute inequality; for example, a 
value of 100 means 100 more cases were prevented or 
postponed in most deprived areas compared with least 
deprived areas, resulting in a decrease in absolute 
inequality. The relative equity slope index takes into 
account the pre-existing socioeconomic gradient of 
disease burden and measures the impact of an inter-
vention on relative inequality. Positive values mean the 
intervention tackles relative inequalities and negative 
values that the intervention generates relative inequal-
ity. Finally, we summarised the overall impact of each 
scenario on CVD burden and equity in the equity 
 summary chart.
doi: 10.1136/bmj.i2793 | BMJ 2016;353:i2793 | the bmj
RESEARCH
4
uncertainty and sensitivity analysis
IMPACTNCD implements a second order Monte Carlo 
design that allows uncertainty to be quantified from the 
outputs. We used distributions to model the uncertainty 
around all scenario specific inputs and the sampling 
error of the risk associated with the CVD related risk fac-
tors. The probabilistic sensitivity analysis has been 
incorporated in our estimates. We summarise the distri-
butions by reporting medians and interquartile ranges 
in the form of first and third fourths. The supplemen-
tary file provides a more detailed description of the 
sources of uncertainty and the relevant distributions.
We ran three further scenarios offering slight varia-
tions on the two primary ones of universal screening 
and population-wide intervention: a universal screen-
ing variation, where we assumed a treatment threshold 
recommendation of 20% risk instead of 10%; another 
variation on universal screening, where we assumed a 
socioeconomic differential in screening uptake, with 
the most deprived of the population to be 10% less 
likely to participate; and a variation on the popula-
tion-wide intervention, where we only modelled dietary 
interventions, excluding smoking interventions. The 
supplementary file provides detailed information on 
the extra scenarios.
validation
We assessed the predictive validity of the IMPACTNCD 
model by comparing the estimated number of deaths 
from CVD with the observed number of deaths from the 
same causes for 2006 to 2013 in England.60 We further 
compared the IMPACTNCD output with CVD mortality 
forecasts from a bayesian age-period-cohort model.61
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
developing plans for design or implementation of the 
study. No patients were asked to advise on interpreta-
tion or writing up of results. There are no plans to dis-
seminate the results of the research to study participants 
or the relevant patient community.
Results
IMPACTNCD outputs for CVD burden and inequality are 
summarised for ages 30 to 84. Because of the assumed 
five year time lag, the interventions affect the popula-
tion from 2016 up to the projection horizon of 2030. The 
impact of the five scenarios on risk factor trajectories 
are further illustrated in additional graphs in the sup-
plementary file.
Overall effectiveness
Under the baseline scenario, IMPACTNCD estimated 
about 1.4 million (interquartile range 1.3-1.5) cases of 
CVD and 540 000 deaths (interquartile range 520 000 to 
550 000) between 2016 and 2030. The most effective 
intervention was the combination of the popula-
tion-wide intervention and concentrated screening. The 
population-wide intervention alone had the second 
highest effectiveness, whereas the universal and the 
concentrated screening scenarios were considerably 
less effective (table 1 ). Despite the improvement of most 
CVD related risk factors, the proportion of high risk peo-
ple in the eligible population is slowly increasing over 
time, because of population aging (fig 1).
socioeconomic inequalities
When socioeconomic inequalities were considered, the 
patterns for reductions in absolute and relative inequal-
ities were similar. The combination of the popula-
tion-wide intervention and concentrated screening 
seemed the most powerful among the simulated inter-
ventions (tables 2 and 3). Concentrated screening alone 
was the second most powerful intervention in tackling 
inequalities, followed by the population-wide interven-
tion. Finally, universal screening of CVD is likely to have 
a small, if any, effect on socioeconomic inequalities.
equity summary chart
We summarised our estimates for the effectiveness and 
equity of the modelled interventions in the equity sum-
mary chart (fig 2). The horizontal axis of the chart rep-
resents the cases of CVD prevented or postponed and 
the vertical axis the reduction in absolute inequality. 
Scenarios above the equity curve (dashed curve in the 
figure) decrease relative socioeconomic inequality, and 
scenarios below the curve increase it. The vertical dis-
tance from the curve approximates the impact of the 
scenario on relative inequality. (See the supplementary 
file for more details about this chart.) The combination 
of the population-wide intervention and concentrated 
screening is by far the most effective and equitable 
intervention. Concentrated screening is also equitable 
but with few mortality gains.
sensitivity analysis
Adding assumptions to extend the scenarios did not 
displace our main findings. The three most notable 
results of the sensitivity analysis were:
Raising the treatment threshold from 10% to 20% fur-
ther reduced the effectiveness of universal screening by 
about 60% in preventing CVD cases. However, in pre-
venting deaths from CVD the effectiveness decreased by 
only 15% as raising the treatment  threshold excludes 
younger participants at intermediate risk from treat-
ment.
Assuming a differential uptake of universal screening 
by deprivation fifth essentially eliminated the estimated 
small potential benefit of universal screening in tack-
ling health inequalities.
A population-wide intervention targeting only diet 
would still be about twice as effective as universal 
table 1 | estimated cases and deaths prevented or postponed under each scenario, by 2030
scenarios
no (interquartile range) prevented or postponed
Cases Deaths
Universal screening 19 000 (11 000-28 000) 3000 (−1000-6000)
Concentrated screening 17 000 (9000-26 000) 2000 (−1000-5000)
Population-wide intervention 67 000 (57 000-77 000) 8000 (4000-11 000)
Population-wide intervention and 
concentrated screening
82 000 (73 000-93 000) 9000 (6000-13 000)
Results rounded to nearest 1000.
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screening and more than twice as effective as popula-
tion-wide intervention targeting smoking alone—so the 
relative ranking of scenario effectiveness would remain 
unaltered. For detailed results see supplementary 
tables S11-S13.
validation
We assessed the predictive validity of the IMPACTNCD 
model by comparing the estimated number of deaths 
from CVD with the observed number of deaths from the 
same cause for 2006 to 2013 in England (fig 3). See the 
supplementary file for detailed graphs by age group, 
sex, deprivation fifth, and disease.
discussion
Our results strongly suggest that universal screening 
and treatment of people at high risk is not the most 
effective option for primary prevention of cardiovas-
cular disease (CVD) overall, nor for reducing socio-
economic inequalities. In contrast, prevention 
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Fig 1 | Proportion of high risk people eligible for universal screening population projections, by age group and sex. 10 year 
risk of cardiovascular disease (CvD) was estimated from QrisK2 score. error bars represent interquartile ranges
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strategies that include population-wide structural 
interventions seem to be the consistently better 
options for reducing overall CVD burden and inequal-
ities. This echoes and quantifies findings from other, 
mostly theoretical, studies supporting that structural 
population-wide interventions are powerful, while 
reducing socioeconomic health inequalities.13 14 62 63 
Indeed, the impact of the population-wide interven-
tion scenario on reduction in estimated mortality and 
inequalities seems compatible with previous esti-
mates, considering the different methodologies.64 
Furthermore, the effectiveness and equity of popula-
tion-wide structural interventions can be further 
improved by the addition of targeted interventions in 
the most deprived groups, as highlighted in the com-
bined scenario of the population-wide intervention 
and concentrated screening.
Compared with other modelling approaches, our 
IMPACTNCD model estimated that NHS Health Checks 
might prevent approximately 1000 non-fatal and 200 
fatal cases of CVD annually. This is comparable with 
the Department of Health estimates of 1600 non-fatal 
CVD cases and 650 deaths prevented annually.4  Fur-
thermore, the Department of Health modelling 
approach assumed an intervention uptake of 75%; 
higher than the current observed levels. Using the 
Archimedes model, Schuetz et al estimated that health 
checks in the UK could prevent some 12 CVD cases per 
1000 population screened after 30 years’ follow-up65 
(7500 CVD cases prevented each year extrapolating to 
the eligible English population). That higher estimate 
reflects the researchers’ apparently unrealistic assump-
tion of 100% screening uptake and 50% overall uptake 
of treatment.
the scenarios
We modelled the universal screening scenario to 
closely resemble the current implementation of the 
NHS Health Check programme, based on published 
evidence. Therefore, we maintain that our estimates on 
the effectiveness of this scenario are not far from the 
real world effectiveness of NHS Health Checks. How-
ever, our output suggesting that universal screening 
might reduce socioeconomic inequalities seems to con-
tradict existing empirical and modelling evidence.14 19-21 
This is because we generously assumed identical 
screening uptake and treatment adherence for all 
socioeconomic groups. In fact, any potential reduction 
in socioeconomic health inequalities was essentially 
eliminated when we considered a small socioeconomic 
differential in uptake in the sensitivity analysis. Fur-
thermore, additional health inequalities may arise 
from differential persistence and adherence to treat-
ment by deprivation status.46
The population-wide intervention scenario on the 
other hand, is based mostly on structural policies tar-
geting price and availability. This scenario potential 
effectiveness was mostly based on natural experi-
ments,66 67  and on previous modelling studies from the 
UK and elsewhere. The size of the changes in the popu-
lation risk factors that we modelled were modest, and 
actually smaller than the reductions observed in coun-
tries such as France, Finland, and the USA during 
recent decades.68-70 This scenario estimated the reduc-
tion in mortality conservatively, because it ignored the 
beneficial effect of the policies on survival from CVD. 
Similarly, it underestimated the reduction of the gap in 
inequalities, because it did not fully consider the cur-
rent disproportionate burden of poor diet among the 
table 3 | relative percentage reduction in cases of cardiovascular disease according to fifth of deprivation by 2030, 
along with relative equity slope index for each scenario
Deprivation fifth*
relative % reduction (interquartile range)
universal screening
Concentrated 
screening
Population-wide 
intervention
Population-wide intervention+ 
concentrated screening
First (least deprived) 1.3 (−0.5-3.1) 0 4.1 (2.2-5.9) 4.0 (2.4-6.0)
Second 1.1 (−0.5-2.9) 0 4.2 (2.2-5.9) 4.0 (2.3-5.9)
Third 1.4 (−0.3-3.2) 0 4.6 (2.8-6.3) 4.4 (2.6-6.2)
Fourth 1.3 (−0.6-3.1) 2.4 (0.6-4.3) 4.6 (2.7-6.6) 6.9 (5.1-8.9)
Fifth (most deprived) 1.6 (−0.2-3.3) 3.6 (1.8-5.3) 6.2 (4.4-8.0) 9.4 (7.6-11.2)
Relative equity slope index 0.4 (−2.4-3.2) 4.9 (1.8-7.9) 2.3 (−0.7-5.3) 6.7 (3.8-9.5)
Results rounded to one decimal place.
*According to index of multiple deprivation.
table 2 | Cases prevented or postponed according to fifth of deprivation by 2030, along with absolute equity slope index 
for each scenario
Deprivation fifth*
no (interquartile range) of cases prevented or postponed
universal screening
Concentrated 
screening
Population-wide 
intervention
Population-wide intervention+ 
concentrated screening
First (least deprived) 3400 (−1400-8300) 0 10 800 (5900-15 500) 10 800 (6200-15 700)
Second 2900 (−1500-8400) 0 12 200 (6200-17 200) 11 500 (6600-17 000)
Third 4000 (−900-9300) 0 13 100 (8100-18 300) 12 600 (7400-17 700)
Fourth 3700 (−1600-8600) 6400 (1500-11 800) 12 500 (7100-18 400) 18 700 (13 900-24 200)
Fifth (most deprived) 4900 (−600-10 400) 10 700 (5300-16 300) 18 700 (13 000-24 000) 28 600 (22 800-33 200)
Absolute equity slope index 1700 (−6200-9300) 14 100 (5700-23 000) 8400 (−400-16 900) 21 100 (12 800-29 300)
Results rounded to nearest 1000.
*According to index of multiple deprivation.
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most deprived of the population,71 and hence the poten-
tial for improvement through population-wide policies.
Finally, the concentrated screening strategy was the 
weakest in terms of overall effectiveness, yet more pow-
erful in tackling inequalities. Its increased impact on 
socioeconomic health inequalities is a direct conse-
quence of the concentrated prevention only to the more 
deprived quantiles of the population. However, the sce-
nario assumptions may not fully hold in real world 
implementation. Hence, concentrated screening rep-
resents a challenge for public health practitioners and 
policymakers to exploit the opportunity of a smaller 
and more homogeneous eligible population and to 
implement better recruitment and tactics for treatment 
adherence. Yet, cost effectiveness might also fall 
because of loss of economies of scale.
Public health implications
This IMPACTNCD modelling may help stakeholders to 
understand better the interplay between preventive pol-
icies, risk factors, disease, and inequalities, and thus 
potentially inform health policy and strategy. Hence, 
when compared with the alternative feasible interven-
tions, universal screening seemed inferior both in pri-
mary prevention and in reducing socioeconomic health 
inequalities. Additionally, we estimated that the pro-
portion of young people at high risk aged less than 60 in 
the eligible population will decrease in future (fig 1). 
This will render universal screening less effective and 
less cost effective for this age group, because a larger 
number will need to be screened to identify each high 
risk individual.
Our study suggests that despite the high clustering of 
risk factors in the most deprived parts of the population, 
structural population-wide approaches remain more 
effective than high risk ones for the prevention of CVD. 
Population-wide approaches also seem to be more effec-
tive in reducing absolute and relative socioeconomic 
health inequalities, generally cost much less than a uni-
versal screening programme, and may even be cost sav-
ing.72 73  In this study, we did not model the full potential 
of these policies, as we focused only on diet and smok-
ing interventions; we did not, for example, incorporate 
alcohol consumption or physical activity. In addition, 
we did not simulate the likely wider benefits of improved 
diet and smoking cessation on the plethora of relevant 
non-communicable diseases. Despite this restricted 
scope, for CVD prevention we estimated that structural 
policies targeting diet could be twice as effective as 
those targeting smoking. Yet, structural interventions 
for a healthier diet are currently underutilised compared 
with tobacco control. Several countries have now intro-
duced taxes on sugary drinks or sugar, including Fin-
land, France, Latvia, and Mexico. The UK has recently 
followed their example. Hungary is the only European 
country currently taxing unhealthy “junk” food.74  How-
ever, fiscal interventions may face opposition from com-
mercial vested interests.75  Interestingly, an increasing 
body of evidence from empirical studies and modelling 
analyses suggest that the maximum health impact with 
a neutral effect on poverty may occur when food or 
drinks taxes are combined with subsidies for healthy 
foods.56 76 77
Moreover, the combination of a population-wide 
intervention with an intervention targeting the most 
deprived members, may further improve effectiveness 
and equity. This approach is in the spirit of proportion-
ate universalism that was identified in the Marmot 
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review as the best approach to tackle socioeconomic 
inequalities in health.78 Our study provides evidence 
that in CVD prevention proportionate universalism may 
be the best option not only for tackling inequalities but 
also for overall effectiveness.
strengths and limitations of this study
IMPACTNCD is the first microsimulation model to synthe-
sise core principles of social and CVD epidemiology, 
vital demographics, published literature, and recent 
health surveys for England to create a synthetic 
 population of England, including socioeconomic struc-
ture, at the individual level. The microsimulation 
approach allows for the simulation of detailed scenar-
ios and explores the distributional nature of their 
impact on the population, in a competing risks frame-
work. Microsimulation allows for greater flexibility and 
more detailed simulation, demanding more statistical 
and computational resources than older approaches; 
we utilised the Farr Institute’s statistical high perfor-
mance computing facilities.79 Many assumptions must 
be made with such models. Yet, despite the potential 
frailty of such assumptions, this model validated well 
against observed CVD mortality, even when multiply 
stratified. Finally, to ensure transparency, we have 
made the IMPACTNCD source code open under GNU 
GPLv3 license.
Models are simplifications of reality and thus possess 
inherent limitations. At least four items were not 
included in the current model. Firstly, the multiplica-
tive risk assumption is considered the status quo in 
comparative risk assessments;80 however, this may 
oversimplify the complex nature of interactions 
between multiple risk factors and disease outcome over 
the life course. Secondly, IMPACTNCD currently ignores 
the effect of risk factors on CVD case fatality, although 
in this study we considered only primary prevention 
scenarios. Thirdly, complex population dynamics such 
as migration, social mobility, and the socioeconomic 
consequences of disease were not modelled. We con-
sider this bias would be relatively small for projections 
with a short horizon. Fourthly, the model ignores the 
impact of universal screening in recognising previously 
undiagnosed cases of atrial fibrillation and other 
opportunistic diagnoses. Reassuringly, most of these 
biases apply across all scenarios; their effects would 
thus be reduced in comparisons between scenarios.
Conclusions
When comparing primary prevention strategies for 
reducing CVD burden and inequalities, universal 
screening seems less effective than alternative strate-
gies that incorporate population-wide approaches. Fur-
ther research is needed to identify the best mix of 
population-wide and risk targeted CVD strategies to 
maximise cost effectiveness and minimise inequalities.
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